ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. - Wikidata - wikimedia - TriplyDB

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

http://www.wikidata.org/entity/Q37540488

about

Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study.

P2860

Q38877010-21CE712E-FF76-4055-8DDD-26E16DBB877A

P2860

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

http://www.wikidata.org/entity/Q37540488

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 June 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@en

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@nl

type

label

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@en

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@nl

prefLabel

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@en

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@nl

P1433

Q37540488-FCF5ED6A-A096-4A83-B7DF-99845F9276DC

P1476

Q37540488-FD12D2EE-A64C-4F95-8E1F-14AFE1D0215C

P2093

Q37540488-0084D781-2E6D-4B46-98CF-32CD0511E12E

Q37540488-1CF91084-48A8-4344-B801-26928FC7D693

Q37540488-27E0E716-DCDA-4619-95B1-E28017C23ACA

Q37540488-2864CDBA-DCDC-483C-8868-0AE2D2CE0184

Q37540488-2CF884DA-FF4F-47F5-B9B8-17D96DC833DD

Q37540488-3CF095DC-4FBD-4660-B993-3062DFF5FF36

Q37540488-8627F181-1B0C-4736-816D-0CC2F034B11D

Q37540488-9274A1F4-EA9A-4DD6-9BE8-78DB9497889D

Q37540488-97247767-CE06-4DED-9A96-1264BD4595B2

Q37540488-A3CBB4FC-B4F7-493E-9D9B-89A449AB1F84

P2860

Q37540488-072C4334-D1EE-47DE-9D6A-EE3937B39E14

Q37540488-1808D976-07F7-441C-8A38-D797538D3110

Q37540488-5D9733DD-5368-4900-ABCD-A38414192249

Q37540488-82F55D0F-13F7-4E16-8BEA-5E4F89EF3CE7

Q37540488-882A5A85-0C16-40FB-8B4C-AA07380721F6

Q37540488-8FF03FD1-6FD4-4495-B6C7-32F70CD1E960

Q37540488-90F977F8-0F6E-4831-9292-DDA8E4B7A53B

Q37540488-91184922-400C-49A2-935D-10D36CBD6783

Q37540488-9197FC04-47FA-4487-90D6-DD6678C91237

Q37540488-946B3B9D-3546-4909-9DA6-60267C4F3D67

P304

Q37540488-F1D64401-5DEF-472F-A936-04FA9DD6D5FA

P31

Q37540488-23E8A87A-11B9-424A-A427-3027598E5B1D

P356

Q37540488-8045C0C5-0065-4301-8F47-298B330A3C34

P433

Q37540488-279230E0-8F07-4422-8717-568F3DF504B2

P478

Q37540488-B717E309-F3D4-4308-B162-A3E557E0062B

P50

Q37540488-09C62005-8C74-4220-A3E6-E74C81D2E525

Q37540488-12DEE628-9DC3-4DA4-B90A-F3C4B8E5F7BA

Q37540488-2C48F887-C973-4512-A09D-371BA9972EB8

Q37540488-3747DEBE-6BEC-44F6-A92D-8B111FFE03AA

Q37540488-4BC99AD6-8F48-4DA0-8205-E0FEA2F4A2B3

Q37540488-723BF0F8-98FD-460F-A6CF-46E9305849C3

Q37540488-92183310-1F8F-4549-9FA9-E80CA50CB870

Q37540488-9558A486-E2DB-4E32-A62E-BB784C837D99

Q37540488-CA81CAE4-37F8-4A76-8E0B-828CA1B204C4

Q37540488-EBDECD34-F07B-440F-9B69-AAD8E95ED442

P577

Q37540488-84D5B865-37EE-4710-8772-0B43EBB3BD7D

P698

Q37540488-3D5AEABB-42C5-42CA-85DF-6AD6E307B838

P921

Q37540488-932A87D4-6D61-4A90-9E1E-F4EBC5B28C18

P932

Q37540488-606D4376-A09C-462E-AED7-341DE191AEBF

P356

J.NEUROBIOLAGING.2015.06.013

P1433

Neurobiology of Aging

P1476

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.

@en

P2093

Anna Ticca

http://www.w3.org/2001/XMLSchema#string

Antonino Cannas

http://www.w3.org/2001/XMLSchema#string

Antonio Canosa

http://www.w3.org/2001/XMLSchema#string

Bryan J Traynor

http://www.w3.org/2001/XMLSchema#string

Daniela Loi

http://www.w3.org/2001/XMLSchema#string

Francesco Marrosu

http://www.w3.org/2001/XMLSchema#string

ITALSGEN and SARDINALS consortia

http://www.w3.org/2001/XMLSchema#string

Leslie D Parish

http://www.w3.org/2001/XMLSchema#string

Marco Barberis

http://www.w3.org/2001/XMLSchema#string

Maria Rita Murru

http://www.w3.org/2001/XMLSchema#string

P2860

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Genetic architecture of ALS in Sardinia

Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.

Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?

Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.

P304

2906.e1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2015.06.013

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Gabriella Restagno

Maria Giovanna Marrosu

Cristina Moglia

Gianluca Floris

Maura Pugliatti

Giuseppe Borghero

P577

2015-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26208502

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

5193218

http://www.w3.org/2001/XMLSchema#string